BRIACELL THERAPEUTICS CORP. Proceeds From Issue Of Ordinary Shares
BRIACELL THERAPEUTICS CORP. (BCTX) reported Proceeds From Issue Of Ordinary Shares of $26.93 million for the 12-month period ending 2021-07-31, per its 40-F/A filed 2021-11-16.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfOrdinaryShares · last filed 2021-11-16
| Period end | Proceeds From Issue Of Ordinary Shares 0 month | Proceeds From Issue Of Ordinary Shares 12 month |
|---|---|---|
| 2021-07-31 | $26.93M 40-F/A · filed 2021-11-16 | |
| 2021-02-26 | $3.90M 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |